我院2011年骨质疏松用药分析  

Usage of anti-osteoporosis drugs in our hospital in 2011

作　　者：王振山[1] 

机构地区：[1]市江苏省老年医院药剂科,南京210024

出　　处：《中国骨质疏松杂志》2012年第8期725-727,708,共4页Chinese Journal of Osteoporosis

摘　　要：目的了解我院骨质疏松用药的基本情况及趋势。方法对我院2011年全年抗骨质疏松药物的销售金额、用药频度及日均费用等进行回顾性分析。结果我院抗骨质疏松用药中阿法骨化醇销售金额最高,DDDs也最高;日均费用以鲑鱼降钙素注射液(密盖息注射液)最高。结论维生素D制剂及钙剂,在防治骨质疏松症的应用中占主导地位,另外降钙素和双膦酸盐在骨质疏松的治疗中也占有重要的地位。Objective To investigate the basic situation and trend of the use of anti-osteoporosis drugs. Methods The consumption sum, usage frequency of drug, and average daily cost of anti-osteoporosis drugs were retrospectively analyzed. Results Alfa-calcidol DDDs and the consumption sum was the most used anti-osteoporosis drugs. The daily cost was the highest in the salmon calcitonin injection. Conclusion Vitamin D and calcium are the mainly used drugs for the prevention and treatment of osteoporosis. Besides, ealcitonin and bisphosphonates also play an important role in the treatment of osteoporosis.

关 键 词：抗骨质疏松药 用药频度 用药分析 

分 类 号：R977[医药卫生—药品]